Ulipristal acetate is now indicated for:
•the intermittent treatment of moderate to severe symptoms of uterine fibroids in women of reproductive age who are not eligible for surgery
•one treatment course of pre-operative treatment of moderate to severe symptoms of uterine fibroids in adult women of reproductive age
Other recommendations include:
· Treatment is to be initiated and supervised by physicians experienced in the diagnosis and treatment of uterine fibroids.
· Treatment is contraindicated in women with underlying liver disorders.
· Discuss the risk of liver damage with women and report any suspected adverse drug reactions.